579 |
VH AMC Clinical Experience |
Duk-Woo Park |
Oct. 10. 08 |
578 |
VH Registry and Clinical Trial Data Review |
James R. Margolis |
Oct. 10. 08 |
577 |
Physiologic Insight of a Bifurcation Lesion |
Bon-Kwon Koo |
Oct. 10. 08 |
576 |
Identification of Vascular Responses to Coronary Stenting by Optical Coherence Tomography: A Sub-Analysis from the Japanese Multi-Center Safety Trial |
Mitsuyasu Terashima |
Oct. 10. 08 |
575 |
Imaging Supported Complex PCI: Heart CT and IVUS |
Satoru Sumitsuji |
Oct. 10. 08 |
574 |
Plaque Stabilization and Regression After Statin Therapy Evaluated With Both Intravascular Ultrasound and Coronary Angioscope |
Junko Honye |
Oct. 10. 08 |
573 |
How To Disclose and What To Be Disclosed: Conflict of Interest for Physicians and Its Implication in Clinical Trial Conduct |
Ted Feldman |
Oct. 02. 08 |
572 |
FDA Perspectives of Clinical Trials in Interventional cardiology: Korean FDA |
Moo Song Lee |
Oct. 02. 08 |
571 |
FDA Perspectives of Clinical Trials in Interventional Cardiology: US FDA |
Angela Smith |
Oct. 02. 08 |
570 |
Nuts and Bolts of Clinical Trials: DSMB, Event Committees, Core Labs, Data Standards |
Ron Waksman |
Oct. 02. 08 |